Overview Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects Status: Completed Trial end date: 2013-08-23 Target enrollment: Participant gender: Summary Objectives: To evaluate the intra-subject variability of the pharmacokinetics (PK) of single oral capsule doses of 20 mg lomitapide. Phase: Phase 1 Details Lead Sponsor: Aegerion Pharmaceuticals, Inc.